Study of Luseogliflozin against hypertension merger diabetes patients
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2017
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 14 Oct 2017 Status changed from active, no longer recruiting to completed.
- 30 Jun 2017 Planned End Date changed from 31 May 2017 to 31 Aug 2017.
- 30 Jun 2017 Status changed from recruiting to active, no longer recruiting.